Unknown

Dataset Information

0

Broad neutralization by a combination of antibodies recognizing the CD4 binding site and a new conformational epitope on the HIV-1 envelope protein.


ABSTRACT: Two to three years after infection, a fraction of HIV-1-infected individuals develop serologic activity that neutralizes most viral isolates. Broadly neutralizing antibodies that recognize the HIV-1 envelope protein have been isolated from these patients by single-cell sorting and by neutralization screens. Here, we report a new method for anti-HIV-1 antibody isolation based on capturing single B cells that recognize the HIV-1 envelope protein expressed on the surface of transfected cells. Although far less efficient than soluble protein baits, the cell-based capture method identified antibodies that bind to a new broadly neutralizing epitope in the vicinity of the V3 loop and the CD4-induced site (CD4i). The new epitope is expressed on the cell surface form of the HIV-1 spike, but not on soluble forms of the same envelope protein. Moreover, the new antibodies complement the neutralization spectrum of potent broadly neutralizing anti-CD4 binding site (CD4bs) antibodies obtained from the same individual. Thus, combinations of potent broadly neutralizing antibodies with complementary activity can account for the breadth and potency of naturally arising anti-HIV-1 serologic activity. Therefore, vaccines aimed at eliciting anti-HIV-1 serologic breadth and potency should not be limited to single epitopes.

SUBMITTER: Klein F 

PROVIDER: S-EPMC3409500 | biostudies-literature | 2012 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Broad neutralization by a combination of antibodies recognizing the CD4 binding site and a new conformational epitope on the HIV-1 envelope protein.

Klein Florian F   Gaebler Christian C   Mouquet Hugo H   Sather D Noah DN   Lehmann Clara C   Scheid Johannes F JF   Kraft Zane Z   Liu Yan Y   Pietzsch John J   Hurley Arlene A   Poignard Pascal P   Feizi Ten T   Morris Lynn L   Walker Bruce D BD   Fätkenheuer Gerd G   Seaman Michael S MS   Stamatatos Leonidas L   Nussenzweig Michel C MC  

The Journal of experimental medicine 20120723 8


Two to three years after infection, a fraction of HIV-1-infected individuals develop serologic activity that neutralizes most viral isolates. Broadly neutralizing antibodies that recognize the HIV-1 envelope protein have been isolated from these patients by single-cell sorting and by neutralization screens. Here, we report a new method for anti-HIV-1 antibody isolation based on capturing single B cells that recognize the HIV-1 envelope protein expressed on the surface of transfected cells. Altho  ...[more]

Similar Datasets

| S-EPMC2584972 | biostudies-literature
| S-EPMC3318667 | biostudies-literature
| S-EPMC4988152 | biostudies-literature
| S-EPMC4665248 | biostudies-literature
| S-EPMC5777257 | biostudies-literature
| S-EPMC3444823 | biostudies-literature
| S-EPMC4249152 | biostudies-literature
| S-EPMC8205970 | biostudies-literature
| S-EPMC3753989 | biostudies-literature
| S-EPMC8936108 | biostudies-literature